- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Dual Role of Interleukin-23 in Epicutaneously-Sensitized Asthma in Mice
-
- Masaki Katsunori
- Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
-
- Suzuki Yusuke
- Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine MSD Endowed Program for Allergy Research, Keio University School of Medicine
-
- Kagawa Shizuko
- Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine MSD Endowed Program for Allergy Research, Keio University School of Medicine
-
- Kodama Motohiro
- Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
-
- Kabata Hiroki
- Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
-
- Miyata Jun
- Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
-
- Tanaka Kyuto
- Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
-
- Fukunaga Koichi
- Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
-
- Sayama Koichi
- Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
-
- Oguma Tsuyoshi
- Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine
-
- Kimura Tokuhiro
- Department of Pathology, Keio University School of Medicine Present address: Department of Pathology, Yamaguchi University Graduate School of Medicine
-
- Amagai Masayuki
- MSD Endowed Program for Allergy Research, Keio University School of Medicine Department of Dermatology, Keio University School of Medicine
-
- Betsuyaku Tomoko
- Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine
-
- Asano Koichiro
- Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine MSD Endowed Program for Allergy Research, Keio University School of Medicine Division of Pulmonary Medicine, Department of Medicine, Tokai University School of Medicine
Search this article
Description
Background: Interleukin (IL)-23/Th17 axis plays an important role in the pathophysiology of asthma and eczema, however, there are some conflicting data about the effects of this system on allergic airway inflammation. In the present study, we aim to dissect the spatiotemporal differences in the roles of IL-23 in an epicutaneously-sensitized asthma model of mice.<br> Methods: C57BL/6 mice were sensitized to ovalbumin (OVA) by patch application on the skin, followed by airway exposure to aerosolized OVA. During sensitization and/or challenge phase, either a specific neutralizing antibody (Ab) against IL-23 or control IgG was injected intraperitoneally. On days 1 and 8 after the final OVA exposure, airway inflammation and responsiveness to methacholine, immunoglobulin levels in serum, and cytokine release from splenocytes were evaluated. Skin Il23a mRNA levels were evaluated with quantitative RT-PCR.<br> Results: Patch application time-dependently increased the expression of Il23a mRNA expression in the skin. Treatment with the anti-IL-23 Ab during sensitization phase alone significantly reduced the number of eosinophils in bronchoalveolar lavage fluids and peribronchial spaces after allergen challenge compared with treatment with control IgG. Anti-IL-23 Ab also reduced serum levels of OVA-specific IgG1. In contrast, treatment with the anti-IL-23 Ab during the challenge phase alone rather exacerbated airway hyperresponsiveness to methacholine with little effects on airway eosinophilia or serum IgG1 levels.<br> Conclusions: IL-23 expressed in the skin during the sensitization phase plays an essential role in the development of allergic phenotypes, whereas IL-23 in the airways during the challenge phase suppresses airway hyperresponsiveness.<br>
Journal
-
- Allergology International
-
Allergology International 63 (Supplement.1), S13-S22, 2014
Japanese Society of Allergology